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’INTRODUCTION
Mononuclear phagocytes (MP; monocytes and tissue macro-
phages)playaprominentroleinhumanimmunodeﬁciencyvirus
(HIV) transmission, viral tissue dissemination, and disease path-
ogenesis.
1 6 Although MP serve as long-lived viral reservoirs,
2
thebiologicaloutcomesofvirus-cellinteractionsaremultifaceted
and can lead to symbiosis or cell death.
1 For the virus, latency,
restriction, or progeny virion production are the ﬁnal outcomes
of cell infection and are closely aligned to cell diﬀerentiation and
activation.
3 Without a doubt, HIV-1 serves as a conductor for its
own regulation, utilizing cross interactions between its own
constituents and MP factors.
4 Importantly, while viral infection
ismodulatedthroughhostcellfactors,thevirus,inturn,inﬂuences
MPfunction.Theinevitableoutcomemaychangeduringtheviral
life cycle and as infection persists.
7 E v e na f t e raq u a r t e rc e n t u r yo f
study, how such events occur and what level of MP viral infection
inﬂuences cytotoxicity remains unclear and poorly deﬁned.
MP protein synthesis can change during diﬀerentiation and
activation orbecuedbythevirus itself toeither propelorrestrict
viral growth.
4 6 As per the latter, cell responses to infection
ultimately break down and sustain viral growth.
8 The mechan-
isms by which such activities occur can now be deciphered
through the advent of new technologies developed for protein
identiﬁcationandquantiﬁcation.Samplingandanalysismaynow
be performed at speciﬁc times following viral exposure and, as
such, could begin to elucidate the biochemical mechanisms
operative during the interplay between the virus and its host
cell. One means to achieve this goal is through stable isotope
labeling of amino acids in cell culture (SILAC). The technique is
used commonly to identify diﬀerential expression of proteins in
studies utilizing cell lines.
9,10 More recently, pulsed SILAC
(pSILAC) was developed for quantitation of de novo cellular
protein synthesis, without the necessity for complete label
incorporation.
11 Application of pSILAC is ideal for studying
nondividingcellsduringdeﬁnedtimeperiodsandforquantifying
diﬀerential protein expression rates.
12 Use of SILAC to assess
macrophage infection, activation, and function is new to cell
biology since it was introduced only two years ago to study
transformed cell lines.
13 17 For the ﬁrst time, we now report
changes in de novo protein synthesis for HIV-1-infected primary
human monocyte-derived macrophages (MDM) as determined
by pSILAC. The identiﬁed MDM responses to HIV-1 infection
included robust changes in synthesis rates of several protein
classes, including those linked to interferon (IFN) signaling and
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ABSTRACT: Dynamic interactions between human immunodeﬁciency virus-1 (HIV-1) and
the macrophage govern the tempo of viral dissemination and replication in its human host.
HIV-1 aﬀects macrophage phenotype, and the macrophage, in turn, can modulate the viral life
cycle. While these processes are linked to host cell function and survival, the precise
intracellular pathways involved are incompletely understood. To elucidate such dynamic
virus cell events, we employed pulsed stable isotope labeling of amino acids in cell culture.
Alterations in de novo protein synthesis of HIV-1 infected human monocyte-derived macro-
phages(MDM)wereexaminedafter3,5,and7daysofviralinfection.Synthesisratesofcellular
metabolic, regulatory, and DNA packaging activities were decreased, whereas, those aﬀecting
antigen presentation (major histocompatibility complex I and II) and interferon-induced
antiviral activities were increased. Interestingly, enrichment of proteins linked to chromatin
assembly or disassembly, DNA packaging, and nucleosome assembly were identiﬁed that
paralleled virus-induced cytopathology and replication. We conclude that HIV-1 regulates a
range of host MDM proteins that aﬀect its survival and abilities to contain infection.
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antigen presentation. The most signiﬁcant protein groupings
were related to cell fusion events, including DNA packaging and
chromatin remodeling. pSILAC oﬀers a comprehensive evalua-
tionofproteinsynthesisdynamicsthatareoperativeduringHIV-
1 infection. The data serves also to validate studies performed in
past decades, while shedding light onto unexplored areas of
cellular responses to progressive HIV-1 infection.
’EXPERIMENTAL PROCEDURES
Cell Culture and Viral Infection
Primaryhumanmonocyteswereobtainedthroughleukophor-
esis of donors that were seronegative for HIV-1, HIV-2, and
hepatitis and were puriﬁed by countercurrent centrifugal elutri-
ation.
18 Cells were plated in Dulbecco’s Modiﬁed Eagle’s Media
supplementedwith10%humanserum,2mM L-glutamine,2μg/
mL macrophage colony stimulating factor (MCSF, a generous
gift from Pﬁzer Inc., Cambridge, MA), 10 μg/mL ciproﬂoxacin
and 50 μg/mL gentamicin (complete media). Three million
cells/well were plated in 6 well plates at a density of one million
cells/mL. Half of the media was exchanged every other day. At
dayseven,mediawasremovedandcellsinfectedwiththeHIV-1ADA
strain at a multiplicity of infection (MOI) of 0.1 infectious viral
particles per cell. Productive HIV-1 infection was monitored
by reverse transcriptase (RT) activity in culture supernatant
ﬂuids collected on days 3, 5, and 7 following HIV-1 infection
(data not shown).
Addition of SILAC Medium
SILAC medium was prepared using two diﬀerent combinations
ofisotopicallylabeled L-Arginineand L-Lysine:“Medium”complete
macrophage media, where L-Arginine and L-Lysine were replaced
with [
13C6]-L-Arginine and [D4]-L-Lysine (SIGMA-Isotec,
StLouis,MO),and“Heavy”completemacrophagemedia,where
L-Arginine and L-Lysine were replaced with [
13C6,
15N4]-
L-Arginine and [
13C6,
15N2]-L-Lysine (SIGMA-Isotec, St Louis,
MO).
12 SILAC media without MCSF was added on days 1, 3, or
5followingHIV-1infectionandcellslysed48hfollowingSILAC
medium addition. “Medium” macrophage media was applied to
uninfectedcontrolcellsand“Heavy”wasappliedtoinfectedcells
(Figure 1). This was repeated with three independent donors.
Cell Lysis and Sample Preparation
After48hincubationinSILACmedia,allmediawasremoved,
cells were washed with PBS and lysed in lysis buﬀer (4% sodium
dodecyl sulfate, 0.1 M dithiothreitol, 0.1 M Tris-HCl, pH 7.6);
cells scraped and collected; and lysates boiled. Protein concen-
trations of the lysates were determined by Pierce 660 Assay
(Thermo Fisher Scientiﬁc, Rockford, IL) At each sample day,
50μgofproteinfrominfectedcellswerecombinedwith50μgof
protein from uninfected control cells. Combined lysates were
diluted in UA (8 M Urea, 0.1 M Tris-Hcl, pH 8.5), applied to a
30 kDa molecular weight cutoﬀ centrifugal ﬁlter (Millipore,
Bellerica, MA), and centrifuged at 14000  g for 15 min. Lysates
were washed with UA and centrifugation was repeated. IAA
(0.5Miodoacetamide)wasaddedtotheﬁlter,incubatedatroom
temperature, and the ﬁlter centrifuged at 14000  g for 10 min.
The ﬁlter unit was washed with UA, and centrifugation was
repeated. ABC (0.05 M NH4HCO3) was added to the ﬁlter,
centrifuged, and repeated once. Two micrograms of trypsin
(Promega, Madison, WI) in ABC was applied to the ﬁlter, mixed
for 1 min, and incubated for 18 h at 37 C in a humidiﬁed
chamber. The ﬁlter-containing digested peptides was transferred
toanewcollectiontubeandcentrifugedat14000 gfor10min.
The ﬁlter was washed with 0.5 M NaCl and centrifuged at
14000 gfor10min[adaptedfromref19].Thedigestedsample
was brought to 1 mL total volume with 0.2% formic acid. The
acidiﬁed protein was added to a wet MXC 30 mg extraction
cartridge (Waters-Oasis, Milford, MA) in 1 mL 50% methanol,
and the cartridge was washed with 1 mL of 5% methanol/0.1%
formic acid, then 100% methanol. The proteins were eluted with
1mLelutionbuﬀer(1.4%NH3OHinmethanol)anddriedusing
a SpeedVac.
Isoelectric Focusing/Fractionation and Mass Spectrometry
Sample Preparations
Dried samples were resuspended and separated by isoelectric
focusingthroughOFFGELelectrophoresis(Agilent,SantaClara,
CA) following the manufacturer’s suggested protocol for separ-
atingpeptides.
20SampleswereseparatedonapH3 10stripand
collected into 12 wells. Wells were washed with 200 μL 50%
methanol/1%formicacid.Washwascollected,driedinaSpeedVac,
and previously collected samples from the corresponding wells
were combined with the dried wash.
21 Fractions collected from
OFFGELelectrophoresisweremixed3partssampleto1part2%
triﬂuoroacetic acid (TFA) and 20% acetonitrile (ACN). C18
spin columns (Thermo Fisher, Rockford, IL) were placed in
collection tubes and activated by the addition 100% ACN,
followed by being washed with 0.5% TFA and 5% ACN. Diluted
samples were applied to the prewet column twice and washed
with 0.5% TFA and 5% ACN. The column was placed in a new
Figure 1. pSILAC experimental design for HIV-1 infection of primary
human macrophages. Control cells were treated for 48 h with [
13C6]-
L-Arginine and [D4]-L-Lysine, while at the same time, HIV-1-infected
cells were treated with [
13C6,
15N4]-L-Arginine and [
13C6,
15N2]-
L-Lysine. MDM were lysed and protein was quantiﬁed. Equal amounts
of protein were combined, separated by OFFGEL electrophoresis,
sequenced by LC MS/MS and quantiﬁed using MaxQuant.2854 dx.doi.org/10.1021/pr200124j |J. Proteome Res. 2011, 10, 2852–2862
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receiver tube, and peptides were eluted with the addition of 70%
ACN. Samples were dried using a SpeedVac and resuspended in
6 μL 0.1% formic acid for LC MS/MS analysis.
Mass Spectrometry
An LTQ Orbitrap XL with Eksigent nano-LC system was
used, equipped with two alternating peptide traps and a PicoFrit
C18 column-emitter (New Objective, Woburn, MA). Samples
were loaded onto the peptide trap with 98:2 HPLC water with
1% formic acid: ACN with 1% formic acid and eluted using a
60 min linear gradient of 0 60% ACN with 1% formic acid. The
instrument was tuned using direct infusion of angiotension and
calibrated every 2 3 days using standards provided by the
manufacturer with Lock Mass. The acquisition method was
created in data-dependent mode with one precursor scan in
the Orbitrap, followed by fragmentation of the 5 most abundant
peaks in the CID, detected in the LTQ. Resolution of the
precursor scan was set to 60000, scanning from 300 to 2000 m/z.
Precursor peaks were dynamically excluded after two selections
for 60 s. No charge state rejection was used, but previously
detectedbackgroundpeakswereincludedinamassrejectionlist.
Collisionenergywassetto35usinganisolationwidthof2andan
activation Q of 0.250.
Quantification and Identification
Files obtained from LTQ-Orbitrap were submitted to Max-
Quant (version 1.0.13.8) for peak list generation. The peak list
ﬁles were searched using Mascot (Matrix Science, Boston, MA)
against the International Protein Index (IPI) human database
for protein identiﬁcations. The search parameters were set as 2
maximum missed cleavages; Carbamidomethyl (C) as ﬁxed
modiﬁcation; N-acetyl (Protein) and Oxidation (M) as variable
modiﬁcations; top 6 MS/MS peaks per 100 Da; and MS/MS
mass tolerance of 0.5 Da. Output ﬁles from Mascot were
submitted back to MaxQuant for ﬁnal identiﬁcations and valida-
tion. MaxQuant was used because of its abilities to provide
quantitative analysis of large mass spectrometric data sets
acquired when performing pSILAC for high-resolution peptide
pair detection. Diﬀerent mass measurements were corrected for
achieving mass accuracy. One unique peptide with a minimum
length of 6 amino acids was required. A false discovery rate of
0.01 was applied for both protein and peptide identiﬁcation,
ensuring that at most only 1% of proteins would be falsely
identiﬁed. Ratios were obtained for HIV-1-infected (“Heavy”)
MDMtoUninfected(“Medium”)MDMcomparisonsfordays3,
5, and 7 following infection. Signiﬁcant protein ratio cutoﬀ
was set at a Signiﬁcance B value e0.05 as calculated by Max-
Quant.
22,23 Since proteins of high abundance have high-intense
signals and can be measured more accurately than ones with low
abundance,weusedtheB-valuebecauseitgroupstheproteinsof
similar intensities into bins of equal occupancy and estimates the
standard deviation of the protein ratios using the protein subset
grouped into the same intensity bin. Contaminants and reverse
hitsidentiﬁedbyMaxQuantwereexcludedfromfurther analysis.
Heatmap was generated using pretty heatmap package in R.
24
Expression pathways were created using Ingenuity Pathway Anal-
ysis(IPA,IngenuitySystems,Inc.,RedwoodCity,CA)version8.8.
Bioinformatic Analyses
The proteins that were determined signiﬁcant by MaxQuant
analyseswereanalyzedwithfunctionalproﬁlingtools.Atwo-step
approach was used where signiﬁcantly diﬀerentially expressed
proteins were ﬁrst selected. For bioinformatic analyses, oﬃcial
gene names corresponding to the proteins identiﬁed were deter-
mined using an internal computational tool. This tool cross-
references databases from ENSEMBL and NCBI (our unpub-
lished work). To obtain gene lists for proteins present uniquely
or commonly among the three time points, the intersection of
genes was determined computationally. Insights into biological
processes were investigated by FatiGO,
25 which uses Gene
Ontology (GO)
26 and Kyoto Encyclopedia of Genes and Gen-
omes (KEGG)
27 for functional annotations. This extended the
search for biological interpretations of the data set to other
databases such as the Reactome and Interpro. Functional sig-
niﬁcance of data collected was measured by Fisher’s exact test
using 2   2 contingency tables. A low p-value of 0.05 indicated a
signiﬁcant association, and the adjusted p-values were calculated
using the false discovery rate (FDR) method.
28
In creating gene lists, an imposition of threshold was per-
formed. The data was analyzed as described, or correlation
analyses were used. The threshold-based method ignores the
cooperative behavioramong genes,whilethecorrelationanalysis
incorporates this property. Using the threshold-based method,
we obtained a total of 297 unique and 57 common genes that
were included in the functional enrichment study. Using the
MaxQuant generated log2(H/M) values from the three experi-
mental time points, gene-to-gene Pearson’s correlation coeﬃ-
cients were calculated. A network of highly correlated genes
(>95%) was used in the construction of a graph network. The
gene network topology was analyzed using Cytoscape 2.6.3,
29
and the densely correlated gene clusters were identiﬁed using
MCODE V1.2
30 available as a plug-in for Cytoscape.
HIV-1p24 Immunohistochemistry
Monocytes were plated at a density of 10
6 cells/mL, propa-
gated in complete media, infected with virus (MOI of 0.1), and
thenstainedforHIV-1p24proteins.Brieﬂy,cellswereﬁxedin4%
paraformaldehyde, permeabilizedwith1%TritonX-100, washed
in PBS, and blocked with 10% bovine serum albumin. HIV-1p24
Ab (Santa Cruz Biotechnology, Santa Cruz, CA) was used at a
1:100 dilution in 10% BSA according to established protocols.
31
’RESULTS AND DISCUSSION
MP display a range of functional innate immune activities for
host survival and homeostasis, including: clearance of debris,
intracellular destruction of pathogens, and secretion and pre-
sentation of bioactive chemicals and peptides that help orches-
trate an immune response. In addition, the same cells serve as
primary targets for a variety of microbial pathogens, including
HIV-1. Indeed, MP support productive HIV-1 infection and are
impacted, in structure and function, by both viral and cellular
products serving to sustain or restrict the viral life cycle.
32 Virus
infection of MP induces a plethora of intracellular activities that
aﬀect antiretroviral immunity but fail, collectively, to eliminate
the viral pathogen. The mechanism(s) by which this occurs
remains incompletely understood. While studies have been
performed to elucidate the host proteins required for HIV-1
infection,
33 little was done to elucidate dynamic host protein
expression during the course of infection in primary macro-
phages. Thus, to better determine the consequences of virus-
macrophage interactions, we employed pSILAC to examine
diﬀerential protein expression during the course of infection.
Thisapproachisnovel,asitallowsexaminationofdenovoprotein
synthesis, and as such, is reﬂective of viral host cell dynamics.2855 dx.doi.org/10.1021/pr200124j |J. Proteome Res. 2011, 10, 2852–2862
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To link viral replication to protein identiﬁcations, we stained
infectedcellsforHIV-1p24todocumentthecourseofHIV-1ADA
infection at the time points examined by proteomics. The
percentages of infected cells increased over time and are illu-
stratedinFigure2.Ondays3,5and7,17.6(3.7,44.0(9.1and
70.7 ( 4.4% of the MDM were HIV-1p24 positive, respectively.
HIV-1ADA MDM infection levels correlated with the formation
ofmultinucleatedgiantcells(Figure2);astageofinfectionwhen
cell death is not prominent.
18 It is understood that cell death can
result after long-standing infection (2 weeks or longer). This
occurs, in part, due to laboratory adaptation of the HIV-1ADA
strain used in study. Virus-induced macrophage death is not
typical of either primary HIV-1 isolates or with the this
current strain when MDM are infected for one week at an
MOI of 0.1.
A total of 393 proteins were identiﬁed as diﬀerentially
expressed, with signiﬁcance values of e0.05 for at least one of
the 3 time points examined after HIV-1 infection (Figure 3a). At
all time points, 28 proteins were identiﬁed as diﬀerentially
expressed. The number of proteins that were identiﬁed between
only two of the time points were similar in quantity, no matter
which overlapping days were examined. Thirty-two, 28, and 24
common proteins with signiﬁcant ratios between infected and
uninfected MDMwereobservedondays3and 5,5and7,or3
and 7 after infection, respectively. The numbers of unique
proteins with diﬀerentially expressed synthesis rates at single
time points were 99, 77, and 105 on days 3, 5, and 7 after
Figure 2. MDM immunostained for HIV-1p24 protein expression
calculated as percent of HIV-1p24 positive cells, expressed as (1
standard deviation of the mean. Illustrated are (A) control, uninfected
MDMandHIV-1-infectedMDMon(B)day3,(C)day5,and(D)day7
after viral infection.
Figure3. (A)Venndiagramoftheoverlapinproteinidentiﬁcationwithsigniﬁcantratios(SigniﬁcanceBe0.05)betweendays3,5,and7.Distributionoflog2
transformed protein expression ratios of HIV-1 to control on (B) day 3, (C) day 5, and (D) day 7 post HIV-1 infection. Ratios are graphed versus intensity.2856 dx.doi.org/10.1021/pr200124j |J. Proteome Res. 2011, 10, 2852–2862
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infection, respectively. These diﬀerences demonstrate that the
cellular response to HIV-1 infection change during the course of
viral infection.
pSILAC ratios were obtained comparing the levels of newly
synthesized proteins in HIV-1-infected MDM to their time-
matched uninfected controls. On each day, there were proteins
with signiﬁcantly diﬀerent ratios, as indicated by B values e0.05,
andwithchanges(upordownregulation)inratesofnewprotein
synthesis between HIV-1 infected cells and replicate uninfected
controls (Figure 3b d). While diﬀerentially expressed proteins
showed similar ﬁndings, their distribution was not constant
during the course of viral infection (Figure 3a). Indeed, MDM
protein levels in response to HIV-1 infection was altered as viral
infection progressed, reﬂecting time-dependent variances in
protein expression rates.
A complete list of all signiﬁcant proteins and their corre-
sponding fold change are included in Supplemental Table 1
(Supporting Information). The highest scoring interaction net-
workidentiﬁedbyIPAforday7ofinfectionidentiﬁedsigniﬁcant
upregulation in de novo synthesis of IFN-induced proteins
(Figure4),therefore,indicatingthattherateofantiviralresponse
by the macrophage increased as HIV-1 infection progressed.
These antiviral proteins aﬀect diﬀerent points during the viral
life cycle (Supplemental Figure 1, Supporting Information).
Although numerous antiviral proteins were up-regulated
[including: 20-50-oligadenylate sythetase 2 (2 5 OAS2), signal
transducers and activators of transcription 1 (STAT1), IFN-
inducedguanylate-bindingprotein1and 2(GBP1, GBP2), IFN-
induced GTP-binding protein Mx1 (Mx1), and bone marrow
stromal antigen 2 (BST2 or tetherin)], virus production in-
creased over time, therefore allowing cells to secrete progeny
virusortospreadinfectiontonearbycells(SupplementalFigure1).
WhileitisknownthatMCSF-diﬀerentiatedmacrophagesdisplay
an M2 anti-inﬂammatory phenotype,
34 it is known that HIV-1
induces an M1 inﬂammatory phenotype at early stages of
infection.
6 This commonly results in IFN production and secre-
tion of pro-inﬂammatory factors
5,35 demonstrating innate anti-
retroviral responses of MDM.
STAT1 was upregulated at all 3 time points that were
examined at 2-day intervals after infection. STAT1 is known to
be an IFN-induced transcription factor (Supplemental Figure 1,
SupportingInformation).Itsexpressionleadstotheinductionof
downstream antiviral genes, such as 2 5 OAS and tetherin,
36
both of which had increased rates of synthesis. Interestingly,
others found that IFN-induction of STAT1 can lead to an initial
phosphorylation of STAT1, but a prolonged upregulation of
unphosphorylated STAT1 can induce antiviral gene expression
independentofSTAT1phosphorylation.
36Thiscouldexplain
the increased and prolonged rates of synthesis of new STAT1
identiﬁed in our study, which translates to upregulation of
antiviral genes and further substantiating that MDM employ
multiple mechanisms to clear virus and permit host cell
survival.
Tetherin binds budding HIV-1 virions to the cell membrane,
and thus inhibits their release. Viral protein U (Vpu) can inhibit
tetherin expression by binding tetherin at the membrane leading
to down-regulation of tetherin at the cell surface
37 (Supple-
mental Figure 1, Supporting Information). Tetherin not only
inhibitsvirionrelease,butalsocell-to-cellviraltransfer.
38Wesaw
an initial down-regulation of tetherin synthesis on D3 that
transitions to up-regulation on D5 and progressing even further
by D7. This increase in the synthesis rate may be an eﬀort to
bypass Vpu inhibition in a futile attempt to control viral prop-
agation. Another IFN-induced antiviral protein, 2 5 OAS2,
exhibited an increased rate of synthesis in our study was shown
to be elevated in individuals aﬄicted with acquired immune
deﬁciency syndrome (AIDS) compared with uninfected controls.
39
In simian immunodeﬁciency virus models, 2 5 OAS2 expres-
sion is elevated in those subjects with a more rapid progression
toward AIDS.
40 HIV-1 is known to have mechanisms to evade
theinterferon-inducedeﬀectsof2 5OAS2.
41Tatbindingtothe
transactivation responsive region of HIV-1 mRNA blocks 2 5
OAS2 binding, therefore preventing 2 5 OAS2 activation.
42
While we have identiﬁed an increasing rate of 2 5 OAS2
synthesis as HIV-1 infection progresses, viral infection is not
diminished as demonstrated by both HIV-1p24 staining and RT
activity. Mx1 and GBP (Supplemental Figure 1) both have roles
in the inhibition of hepatitis C.
43,44 Mx1 also has been impli-
catedininhibiting inﬂuenza viral growth,
45andGBP isknown to
inhibit both vesicular stomatitis and encephalomyocarditis
viruses.
46 MX1 induction during HIV-1 infection has been iden-
tiﬁed by multiple groups.
47 Thus, extensive identiﬁcation of IFN-
induced antiviral proteins that have increased synthesis during
HIV-1 infection conﬁrms pSILAC as a suitable technology for
detecting protein synthesis changes in nondividing MDM.
ENSEMBL Gene Identiﬁers for corresponding proteins with-
inagroupwereobtainedforfunctionalclassiﬁcationofidentiﬁed
proteins. The number of unique genes identiﬁed for the three
daysarelistedinTable1andwerefurtheranalyzedforfunctional
classiﬁcation. To begin looking for novel protein synthesis
changes that occurred during HIV-1 infection of MDM and
were identiﬁed by pSILAC, corresponding genes were grouped
by their functional classiﬁcation using FatiGO, a functional en-
richment tool available in the Babelomics software. Only group-
ingsofgenesscoringap-valuee0.01wereconsidered signiﬁcant
and used for further analyses. We examined GO terms that
contained signiﬁcant groupings of unique proteins identiﬁed in a
minimumoftwotimepoints.Tothisend,asigniﬁcantnumberof
protein groups on each of the days corresponded to one GO
term, but the individual proteins identiﬁed between days were
unique. Such analyses bridged the data set to functional biology
of the macrophage. Inthis way,theimpact of protein groupswith
speciﬁcfunctionswasrealizedassigniﬁcantforvirus-infectedcells.
Through investigations of new protein synthesis observed
during short time periods, we can elucidate an evolving MDM
response to HIV-1 infection. Understanding the compensatory
changes in MP biology after viral infection is key to identifying
both how the cell responds to progressive HIV-1 infection and
themechanismsbywhichHIV-1modulatesthecellularresponse
to its beneﬁt. In this regard, a number of cellular protein classes
changed their rate of synthesis as a consequence of infection.
While many groups of proteins were determined to be signiﬁ-
cantly altered, we chose to focus our attention on the most en-
richedfunctionalgroupings;thosegroupedundertheGOterms:
telomere maintenance, chromatin assembly or disassembly,
DNApackaging,andnucleosomeassembly.Eachofthesegroups
is marked with an asterisk in Table 2 and had a minimum of 15
unique genes associated with D7 or D3 along with separate
unique genes associated with all three days of infection. While
telomere maintenance was identiﬁed as an enriched grouping,
these proteins were all histones, known to be involved in cellular
regulatory processes. Proteins linked only to the maintenance of
telomeres were not identiﬁed and would be expected since
human MDM are nondividing cells. The groupings related to2857 dx.doi.org/10.1021/pr200124j |J. Proteome Res. 2011, 10, 2852–2862
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Figure 4. (A) IFN signaling pathway coded with identiﬁed proteins on day 7 postinfection. Gray proteins were identiﬁed but did not reach statistical
signiﬁcance. (B) Ingenuity Pathway Analysis highest scoring interaction network. Increased synthesis rates are indicated by increasing intensity of red;
decreased synthesis rates are denoted in green.2858 dx.doi.org/10.1021/pr200124j |J. Proteome Res. 2011, 10, 2852–2862
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the control of DNA packaging andchromatinassemblyarelikely
linkedtovirus-inducedcytopathology, whichishighlysigniﬁcant
for the HIV-1ADA strain.
MaxQuant protein groups were also examined in parallel for
interactions between one another and to provide conﬁrmation
andextensionsoftheproteinmaps.Indeed,byperformingcluster
analysis, we selected two clusters that included interactions from
highly signiﬁcant groupings that are linked to macrophage func-
tions. The ﬁrst cluster demonstrates speciﬁc interactions between
DNA packaging, chromatin assembly/disassembly, and nucleo-
some assembly, along with fatty acid oxidation and antigen
processing and presentation (Figure 5, Supplemental Figure 2,
Supporting Information). In the second cluster, we identiﬁed
interactions that appeared to split between two distinct groups
(SupplementalFigures3and4,SupportingInformation).Theﬁrst
was between transcription initiation, nucleosome assembly, chro-
matin assembly/disassembly, DNA packaging, second messenger
signaling and phosphoinositide-mediated signaling. The second
wasinvolvedintheimmunesystemanddevelopmentalregulation,
including negative regulation of cellular diﬀerentiation, regulation
of immune system processes, myeloid cell diﬀerentiation, mega-
karyocytediﬀerentiation,hemopoiesis,andimmunesystemdevel-
opment.Athird,butlesssigniﬁcant,contributorwastheregulation
of ubiquitin-protein ligase activity (both positive and negative).
The cytopathology of HIV-1 infected MDM has been the topic
of previous studies investigating cytoskeletal transformation,
multinucleated giant cell formation, and HIV-1-associated
neurodegeneration.
8,35 Less studied are the protein changes
resulting in these cytopathological ﬁndings. The epigenetic
control of HIV-1 viral latency has been the subject of many
recent studies and helps to explain the cytopathicity of HIV-1
infection. While histone methylation, acetylation and deacetyla-
tion are utilized to control viral integration and expression,
48
histonesynthesisandturnoverisanareathathasnotbeenheavily
investigated in relation to HIV-1 infection. We identiﬁed diﬀer-
ential regulation in the synthesis rates of histone proteins, which
are seen in our signiﬁcant GO groupings (Figure 6). Signiﬁcant
down-regulation in synthesis rates were identiﬁed in some
histones by D3 post infection, and further down-regulation in
the rates of protein synthesis were identiﬁed by days 5 and 7
following infection. Such a response is made when the host cell
works to restrict viral dissemination in MDM. Indeed, histone
recycling during transcription is thought to occur when it is
necessary to replace modiﬁed histones, such as those that are
methylated.
49
In recent years, it has been determined that modiﬁed histones
are often controlled by such molecules as histone methyltrans-
ferases, acetyltransferases,and deacetylases, without the need for
histone recycling. In contrast, histone replacement from cellular
pools is necessary following unwinding during transcription,
substantiating the need for histone turnover for active tran-
scription.
50 HIV-1 infection results in chromatin disruption,
which likely contributes to the accessibility of transcription
initiation sites to polymerases in productively infected cells.
51
Therefore, it is required to rearrange DNA packaging for
successful proviral DNA insertion and subsequent transcription.
Whilethelocationandmodiﬁcationstatusofhistonescommonly
have been examined,
52 along with other mechanisms of epige-
netic control of viral replication,
53 the rate of new histone
synthesis has not been evaluated as a consequence of HIV-1
infection. Indeed, decreasing synthesis rates of macrophage
histone proteins may therefore serve a dual function in altering
Table 2. Functional Annotation of Genes Using Babelomics
a
number of unique genes
GO Terms knowledgebase used day 3 day 5 day 7 common (day 3, 5, 7)
30 -UTR-mediated translational regulation Reactome 4 4
APC/C:Cdh1-mediated degradation of Skp2 Reactome 3 5
Cdc20:Phospho-APC/C mediated degradation of Cyclin A Reactome 3 5
Cell cycle, Mitotic Reactome 7 7
Diabetes pathways Reactome 7 7
DNA replication Reactome 4 5
Gene expression Reactome 7 8
HIV infection Reactome 4 7
Metabolism of amino acids Reactome 5 7
Regulation of activated PAK-2p34 by proteasome mediated degradation Reactome 3 5
Signaling by Wnt Reactome 3 5
Telomere Maintenance* Reactome 15 8
Fatty acid metabolism Kegg Pathway 4 4
Proteasome Kegg Pathway 3 5
Chromatin assembly or disassembly* Biological Process 20 27
DNA packaging* Biological Process 21 27
Nucleosome assembly* Biological Process 18 27
aNumbers in each column correspond to the number of unique genes expressed only at that day.
Table 1. Number of Unique Genes Used for Babelomics
Functional Annotation Following Parsing of Original Signif-
icant MaxQuant Protein Groupings
treatment
signiﬁcant MaxQuant
proteins
ENSEMBLE gene
identiﬁers
unique
genes
Day 3 184 221 98
Day 5 165 201 76
Day 7 186 248 1232859 dx.doi.org/10.1021/pr200124j |J. Proteome Res. 2011, 10, 2852–2862
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cellular structure and metabolism. First, it may permit improved
engagement of the HIV-1 promoter to facilitate active viral
replication, and second, an overall decrease in transcription, or
rearrangement of chromatin, can eﬀect more globally altered
gene expression as the host works to protect the cell from ongo-
ing virus-induced damage.
The ﬁndingsalsosupportthe idea that the macrophagehas an
initial burst in protein synthesis rates required for antigen (AG)
presentation to both CD4þ and CD8þ T cells as an attempt to
control viral infection. This response is likely attenuated over
time as the mechanism by which macrophages work to clear
virus and protect the host, shifts and begins to break down.
Figure 5. Enriched protein classiﬁcations for the correlation network in Supplemental Figure 2 (Supporting Information).2860 dx.doi.org/10.1021/pr200124j |J. Proteome Res. 2011, 10, 2852–2862
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Interestingly, the AG presentation protein group includes a
variety of major histocompatibility complex (MHC) class I and
MHCclassIIproteins.Itssynthesiswasmostheavilyupregulated
at day 3 compared with the later days, 5 and 7, of infection
(Figure 6). As virus replication progressed, AG presentation-
related protein synthesis rates consistently increased compared
to controls; but the level of upregulation was decreased over
time. It is noteworthy that AG presentation to T cells is a major
function of macrophages and represents, along with phagocyto-
sis, intracellular killing, mobility, and secretion of bioactive
substances, the host’s primary defense in engaging an immune
response to contain microbial infection. Thus, up-regulation in
both, MCH Class I and II AG presenting proteins that are
reduced as HIV-1 infection ensues, likely follows a cellular
response to control this ongoing microbial infection. During
early infection, before large increases in viral replication over-
whelms cellular control capacities, the macrophage attempts to
controlvirusthrough itsAGpresentation capabilities.Insupport
of this notion, and recently seen by others, Nef was implicated in
both MHC I
54 and MHC II
55 down-regulation, further substan-
tiating that HIV-1 modulates the macrophage to its beneﬁt.
Indeed, we found that as HIV-1 infection progresses, AG
presentation activities are diminished. This can be due to a
combination of cellular responses including Nef inhibition and
modulation of macrophage protein expression leading to en-
hanced cell survival.
’CONCLUSION
Taken together our data support the idea that a delicate
interplay exists between host survival and macrophage viral
propagation. While ultimately HIV-1 persistence prevails, intri-
cate cellular and viral regulatory events occur as the macrophage
workstocontainHIV-1infection,despitetheinevitableoutcome
tothecell.HIV-1inturnacquiresuniqueprotectivemechanisms
tosupportitsownsurvival,whilealteringtheMDMtoitsbeneﬁt.
Indeed,ourstudyhighlightsarangeofantiretroviralmechanisms
that develop in the macrophage for its beneﬁt. Down-regulation
of histone synthesis rates is one that portends more global
outcomes for the cell. Altering DNA packaging ultimately alters
transcription rates andcellprocess regulation. Ultimately,HIV-1
overcomes the antiretroviral macrophage protein armada. While
working to contain viral growth, the macrophage fails, inevitably
giving the virus and its dissemination the overriding edge. The
future rests in ﬁnding the means to boost macrophage
antiretroviral activities with the goal to both contain, then
eliminate viral infection.
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